Bcl-2 inhibitor AT101 acetic acid, Purity ≥98%

Cat. No.: X23-10-ZQ035

Bcl-2 inhibitor AT101 acetic acid, Purity ≥98%

Synonym: 12542-36-8; 866541-93-7; Gossypol acetic acid; Gossypol-acetic acid; Gossypol acetate; Acetate gossypol; AT101; 1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-[2,2'-binaphthalene]-8,8'-dicarbaldehyde acetate salt; Bcl-2 inhibitor

  • MDL: MFCD00058385
  • CAS Number: 866541-93-7
  • Compound CID: 227456
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AT101 acetic acid, soluble in DMSO and ethanol and insoluble in water, specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells. It targets Mcl-1, Bcl-2, and Bcl-xL.
Molecular Weight
578.61
Molecular Formula
C30H30O8.C2H4O2
Targets
Mcl-1: 0.18 μM (Ki); Bcl-2: 0.32 μM (Ki); Bcl-xL: 0.48 μM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 108 mg/mL (186.65 mM); Water: Insoluble; Ethanol: 83 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AT101 acetic acid can be applied to research involving the inhibition of Bcl-2 family proteins and its effects on inducing apoptosis in cancer cells.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.